Q98439007

Summary

Q98439007 is an interpellation^[1].

Key Facts

• Q98439007 authored Meeri Wasberg^[2].
• Q98439007's instance of is recorded as interpellation^[3].
• Q98439007's part of the series is recorded as interpellations of the 2012/13 legislative session of the Riksdag^[4].
• Q98439007's language of work or name is recorded as Swedish^[5].
• Q98439007's publication date is recorded as +2013-02-14T00:00:00Z^[6].
• Q98439007's significant event is recorded as debate^[7].
• Q98439007's main subject is recorded as medication^[8].
• Q98439007's work available at URL is recorded as http://data.riksdagen.se/dokument/H010271^[9].
• Q98439007's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H010271^[10].
• Q98439007's applies to jurisdiction is recorded as Sweden^[11].
• Q98439007's legal citation of this text is recorded as ip. 2012/13:271^[12].
• Q98439007's title is recorded as Receptfria läkemedel^[13].
• Q98439007's addressee is recorded as Göran Hägglund^[14].
• Q98439007's maintained by WikiProject is recorded as Project Riksdagen's documents^[15].
• Q98439007's copyright status is recorded as public domain^[16].
• Q98439007's Swedish Riksdag document ID is recorded as H010271^[17].

Body

Works and Contributions

Q98439007 authored Meeri Wasberg^[2].